Abstract
Nanomedicine is an interdisciplinary approach that involves toxicology and other medicinal applications. Gold nanoparticles (AuNPs) may serve as a promising model to address the size and shape‐dependent biological response because they show good biocompatibility. This study is to prepare phytosynthesis AuNPs from ten different Cassia sp. Among them, the aqueous leaf extract of C. roxburghii produced greater efficient and stable AuNPs. The AuNPs were optimised for different physicochemical conditions. Highly stable AuNPs were synthesised at pH 7.0, 37°C, 1.0 ml of C. roxburghii leaf extract and 1.0 mM concentration of HAuCl4 with the particle size of ∼50 nm and these AuNPs were stable up to 12 months. To determine the safety profile of AuNPs in‐vivo, the nanoparticles were injected intravenously into male Wistar albino rats in varying dosages. The authors noticed no significant difference in body weights, haematological and biochemical parameters and the histopathological sections of all vital organs. Highest accumulation was seen in spleen and least in brain. The authors’ results show that the AuNPs were biocompatible and did not produce any adverse or abnormalities in‐vivo. The implications of the bioaccumulation of AuNPs need to be further studied to rule out any adverse effects on long‐term exposure.